Cite
Utility of the lateral flow urine lipoarabinomannan tuberculosis assay in patients with advanced HIV disease at antiretroviral therapy centres in Mumbai, India.
MLA
Acharya, Shrikala, et al. “Utility of the Lateral Flow Urine Lipoarabinomannan Tuberculosis Assay in Patients with Advanced HIV Disease at Antiretroviral Therapy Centres in Mumbai, India.” PLoS ONE, vol. 17, no. 9, Sept. 2022, pp. 1–16. EBSCOhost, https://doi.org/10.1371/journal.pone.0273970.
APA
Acharya, S., Deshpande, P., Asirvatham, E. S., Palkar, A., Sarman, C. J., Laxmeshwar, C., Setia, M. S., Rathod, D., Koli, S., Dale, J., Yeldandi, V., Allam, R., Agarwal, R., Verma, S., Upadhyaya, S., & Nyendak, M. (2022). Utility of the lateral flow urine lipoarabinomannan tuberculosis assay in patients with advanced HIV disease at antiretroviral therapy centres in Mumbai, India. PLoS ONE, 17(9), 1–16. https://doi.org/10.1371/journal.pone.0273970
Chicago
Acharya, Shrikala, Prashant Deshpande, Edwin Sam Asirvatham, Amol Palkar, Charishma Jones Sarman, Chinmay Laxmeshwar, Maninder Singh Setia, et al. 2022. “Utility of the Lateral Flow Urine Lipoarabinomannan Tuberculosis Assay in Patients with Advanced HIV Disease at Antiretroviral Therapy Centres in Mumbai, India.” PLoS ONE 17 (9): 1–16. doi:10.1371/journal.pone.0273970.